Literature DB >> 31257206

Hyperactive GPIb-von Willebrand factor interaction as cause of thrombocytopenia: altered platelet formation versus clearance.

Kathleen Freson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31257206      PMCID： PMC6601106          DOI： 10.3324/haematol.2019.219832

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Impaired megakaryocytopoiesis in type 2B von Willebrand disease with severe thrombocytopenia.

Authors:  Paquita Nurden; Najet Debili; William Vainchenker; Regis Bobe; Raymonde Bredoux; Elisabeth Corvazier; Robert Combrie; Edith Fressinaud; Dominique Meyer; Alan T Nurden; Jocelyne Enouf
Journal:  Blood       Date:  2006-05-23       Impact factor: 22.113

2.  LIM kinase/cofilin dysregulation promotes macrothrombocytopenia in severe von Willebrand disease-type 2B.

Authors:  Alexandre Kauskot; Sonia Poirault-Chassac; Frédéric Adam; Vincent Muczynski; Gabriel Aymé; Caterina Casari; Jean-Claude Bordet; Christelle Soukaseum; Chantal Rothschild; Valérie Proulle; Audrey Pietrzyk-Nivau; Eliane Berrou; Olivier D Christophe; Jean-Philippe Rosa; Peter J Lenting; Marijke Bryckaert; Cécile V Denis; Dominique Baruch
Journal:  JCI Insight       Date:  2016-10-06

3.  Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.

Authors:  H J Weiss; D Meyer; R Rabinowitz; G Pietu; J P Girma; W J Vicic; J Rogers
Journal:  N Engl J Med       Date:  1982-02-11       Impact factor: 91.245

4.  Frequency of platelet type versus type 2B von Willebrand disease. An international registry-based study.

Authors:  Alexander Hamilton; Margareth Ozelo; Jayne Leggo; Colleen Notley; Hannah Brown; Juan Pablo Frontroth; Anne Angelillo-Scherrer; Fariba Baghaei; Said M Enayat; Emmanuel Favaloro; David Lillicrap; Maha Othman
Journal:  Thromb Haemost       Date:  2011-02-08       Impact factor: 5.249

5.  Expression of the phenotypic abnormality of platelet-type von Willebrand disease in a recombinant glycoprotein Ib alpha fragment.

Authors:  M Murata; S R Russell; Z M Ruggeri; J Ware
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

Review 6.  Altered megakaryocytopoiesis in von Willebrand type 2B disease.

Authors:  A T Nurden; A B Federici; P Nurden
Journal:  J Thromb Haemost       Date:  2009-07       Impact factor: 5.824

7.  Type 2B von Willebrand disease associated with the release of platelet agglutinates from megakaryocytes in the bone marrow.

Authors:  William B Slayton; Milin Patel; Martha Sola-Visner; Neil Harris; Angela Rivers; Robert R Montgomery; Kenneth D Friedman
Journal:  J Pediatr Hematol Oncol       Date:  2008-09       Impact factor: 1.289

8.  Accelerated uptake of VWF/platelet complexes in macrophages contributes to VWD type 2B-associated thrombocytopenia.

Authors:  Caterina Casari; Vivian Du; Ya-Ping Wu; Alexandre Kauskot; Philip G de Groot; Olivier D Christophe; Cécile V Denis; Bas de Laat; Peter J Lenting
Journal:  Blood       Date:  2013-08-14       Impact factor: 22.113

9.  Apoptotic Platelet Events Are Not Observed in Severe von Willebrand Disease-Type 2B Mutation p.V1316M.

Authors:  Eliane Berrou; Alexandre Kauskot; Frédéric Adam; Amélie Harel; Paulette Legendre; Cécile Lavenu Bombled; Chantal Rothschild; Nicolas Prevost; Olivier D Christophe; Peter J Lenting; Cécile V Denis; Jean-Philippe Rosa; Marijke Bryckaert
Journal:  PLoS One       Date:  2015-12-08       Impact factor: 3.240

10.  Platelet clearance via shear-induced unfolding of a membrane mechanoreceptor.

Authors:  Wei Deng; Yan Xu; Wenchun Chen; David S Paul; Anum K Syed; Matthew A Dragovich; Xin Liang; Philip Zakas; Michael C Berndt; Jorge Di Paola; Jerry Ware; Francois Lanza; Christopher B Doering; Wolfgang Bergmeier; X Frank Zhang; Renhao Li
Journal:  Nat Commun       Date:  2016-09-27       Impact factor: 14.919
View more
  1 in total

1.  Clinical management, ethics and informed consent related to multi-gene panel-based high throughput sequencing testing for platelet disorders: Communication from the SSC of the ISTH.

Authors:  Kate Downes; Pascal Borry; Katrin Ericson; Keith Gomez; Andreas Greinacher; Michele Lambert; Eva Leinoe; Patrizia Noris; Chris Van Geet; Kathleen Freson
Journal:  J Thromb Haemost       Date:  2020-10       Impact factor: 5.824
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.